Literature DB >> 17991356

Operative management of primary epithelial ovarian cancer.

Mario M Leitao1, Dennis S Chi.   

Abstract

Surgery plays an integral part in the primary management of early-stage and advanced-stage epithelial ovarian cancer. Surgical staging is essential for disease grossly confined to the ovaries or pelvis. Comprehensive surgical staging often results in upstaging of patients who were presumed to be at an early stage. Accurate staging has an impact on prognosis and treatment strategies. Optimal surgical cytoreduction leads to improved outcomes in patients with advanced disease; before initiation of chemotherapy, it offers the most favorable outcome and should be offered to all patients. Intraperitoneal catheters for postoperative chemotherapy instillation may be offered and placed at the time of cytoreduction. Neoadjuvant chemotherapy and interval cytoreduction are a possibility for patients who are not amenable to an optimal cytoreduction based on preoperative findings or in those who are at extremely high risk for surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17991356     DOI: 10.1007/s11912-007-0067-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  39 in total

1.  Carcinoma of the ovary.

Authors:  A P Heintz; F Odicino; P Maisonneuve; U Beller; J L Benedet; W T Creasman; H Y Ngan; M Sideri; S Pecorelli
Journal:  J Epidemiol Biostat       Date:  2001

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

Authors:  D S Chi; E L Eisenhauer; J Lang; J Huh; L Haddad; N R Abu-Rustum; Y Sonoda; D A Levine; M Hensley; R R Barakat
Journal:  Gynecol Oncol       Date:  2006-05-22       Impact factor: 5.482

4.  Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Authors:  Craig C Earle; Deborah Schrag; Bridget A Neville; K Robin Yabroff; Marie Topor; Angela Fahey; Edward L Trimble; Diane C Bodurka; Robert E Bristow; Michael Carney; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

5.  The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions.

Authors:  Margrit M Juretzka; Nadeem R Abu-Rustum; Yukio Sonoda; Robert J Downey; Raja M Flores; Bernard J Park; Martee L Hensley; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2006-12-05       Impact factor: 5.482

6.  Intraoperative clinical evaluation of lymph nodes in women with gynecologic cancer.

Authors:  G H Eltabbakh
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

7.  Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

Authors:  Dennis S Chi; Corinna C Franklin; Douglas A Levine; Faina Akselrod; Paul Sabbatini; William R Jarnagin; Ronald DeMatteo; Elizabeth A Poynor; Nadeem R Abu-Rustum; Richard R Barakat
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

8.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

9.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272

10.  Lymphadenectomy in stage I ovarian cancer.

Authors:  E Petru; M Lahousen; K Tamussino; H Pickel; H Stranzl; H Stettner; R Winter
Journal:  Am J Obstet Gynecol       Date:  1994-02       Impact factor: 8.661

View more
  2 in total

1.  Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy.

Authors:  Joseph Menczer; Angela Chetrit; Siegal Sadetzki
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Uterine involvement in epithelial ovarian cancer and its risk factors.

Authors:  Narges Zamani; Azam Sadat Mousavi; Setare Akhavan; Shahrzad Sheikhhasani; Somayeh Nikfar; Elham Feizabad; Elahe Rezayof; Mitra Modares Gilani
Journal:  J Ovarian Res       Date:  2021-12-07       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.